Thiard News@F4F

@newsen.bsky.social

4 months ago

EpiVax and FDA Unveil New Insights on Generic Teriparatide Risks EpiVax, in collaboration with the FDA, reveals findings on immunogenicity risks linked to impurities in generic teriparatide, ensuring drug safety.

EpiVax and FDA Unveil New Insights on Generic Teriparatide Risks #USA #FDA #Providence #EpiVax #Teraparatide

Thiard News@F4F

@newsen.bsky.social

4 months ago

EpiVax and FDA Reveal New Insights on Immunogenicity Risks in Generic Teriparatide Products EpiVax, in collaboration with FDA scientists, uncovers critical findings on the immunogenicity risks associated with peptide impurities in generic Teriparatide.

EpiVax and FDA Reveal New Insights on Immunogenicity Risks in Generic Teriparatide Products #USA #FDA #EpiVax #Providence,_RI #Teriparatide

Thiard News@F4F

@newsen.bsky.social

4 months ago

EpiVax and FDA Collaborate to Assess Immunogenicity Risks of Peptide Impurities in Generic Teriparatide Discover how EpiVax and the FDA's recent study identifies immunogenicity risks linked to peptide impurities in generic teriparatide products, ensuring patient safety.

EpiVax and FDA Collaborate to Assess Immunogenicity Risks of Peptide Impurities in Generic Teriparatide #USA #FDA #Providence #EpiVax #Teriparatide

Thiard News@F4F

@newsen.bsky.social

4 months ago

EpiVax and FDA Collaborate on Immunogenicity Risks in Generic Teriparatide: Breakthrough Insights EpiVax, in partnership with the FDA, has unveiled new findings on the immunogenicity risks posed by peptide-related impurities in generic teriparatide, vital for drug safety.

EpiVax and FDA Collaborate on Immunogenicity Risks in Generic Teriparatide: Breakthrough Insights #USA #FDA #Providence #EpiVax #Teriparatide

Thiard News@F4F

@newsen.bsky.social

4 months ago

EpiVax and FDA Collaborate to Uncover Immunogenicity Risks in Generic Teriparatide EpiVax and FDA scientists unveil vital findings on the immunogenic risks posed by peptide-related impurities in generic teriparatide, enhancing drug safety.

EpiVax and FDA Collaborate to Uncover Immunogenicity Risks in Generic Teriparatide #USA #FDA #Providence #EpiVax #Teriparatide

Thiard News@F4F

@newsen.bsky.social

10 months ago

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer to Drive Scientific Strategy EpiVax has announced the appointment of Dr. Vibha Jawa as Chief Scientific Officer, succeeding founder Annie De Groot. Dr. Jawa brings over 20 years of expertise in biopharmaceuticals.

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer to Drive Scientific Strategy #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

Thiard News@F4F

@newsen.bsky.social

10 months ago

EpiVax Appoints Dr. Vibha Jawa as New Chief Scientific Officer to Lead Scientific Strategy EpiVax, a leader in preclinical immunogenicity assessment, announces the appointment of Dr. Vibha Jawa as CSO, succeeding Dr. Annie De Groot.

EpiVax Appoints Dr. Vibha Jawa as New Chief Scientific Officer to Lead Scientific Strategy #United_States #Providence #EpiVax #Immunogenicity #Dr._Vibha_Jawa

Thiard News@F4F

@newsen.bsky.social

10 months ago

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer, Promising Innovative Advancements EpiVax has appointed Dr. Vibha Jawa as its new Chief Scientific Officer. With over 20 years in biotech, she will lead advancements in immunogenicity.

EpiVax Appoints Dr. Vibha Jawa as Chief Scientific Officer, Promising Innovative Advancements #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

Thiard News@F4F

@newsen.bsky.social

10 months ago

EpiVax Welcomes Dr. Vibha Jawa as the New Chief Scientific Officer to Enhance Scientific Strategy EpiVax announces the appointment of Dr. Vibha Jawa as Chief Scientific Officer, aiming to further their mission in immunogenicity assessment and biologic therapeutics.

EpiVax Welcomes Dr. Vibha Jawa as the New Chief Scientific Officer to Enhance Scientific Strategy #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

Thiard News@F4F

@newsen.bsky.social

10 months ago

EpiVax Welcomes Dr. Vibha Jawa as Chief Scientific Officer to Propel Innovation EpiVax appoints Dr. Vibha Jawa as Chief Scientific Officer, marking a pivotal leadership transition aimed at advancing immunogenicity assessment in biologics.

EpiVax Welcomes Dr. Vibha Jawa as Chief Scientific Officer to Propel Innovation #USA #Providence #EpiVax #Immunogenicity #Vibha_Jawa

Thiard News@F4F

@newsen.bsky.social

11 months ago

New Study Reveals Treg Epitope Role in Antibody Maturation: Implications for Therapeutics EpiVax's groundbreaking study unveils the influence of Treg epitopes on antibody maturation, offering new insights into therapeutic antibodies and immune responses.

New Study Reveals Treg Epitope Role in Antibody Maturation: Implications for Therapeutics #USA #Providence #EpiVax #Treg_Epitope #Antibody_Maturation

Thiard News@F4F

@newsen.bsky.social

11 months ago

EpiVax Reveals the Role of Tregitopes in Antibody Maturation and Implications for Therapeutic Applications A recent EpiVax study uncovers how Tregitopes influence antibody maturation, showcasing implications for therapeutic antibody development.

EpiVax Reveals the Role of Tregitopes in Antibody Maturation and Implications for Therapeutic Applications #USA #Providence #EpiVax #Immunology #Tregitopes

Thiard News@F4F

@newsen.bsky.social

11 months ago

New EpiVax Study Reveals Role of Tregitopes in Antibody Maturation and Therapeutic Implications EpiVax has unveiled a significant study exploring the effects of Tregitopes on antibody maturation, providing critical insights for therapeutic antibody development.

New EpiVax Study Reveals Role of Tregitopes in Antibody Maturation and Therapeutic Implications #USA #Providence #EpiVax #Immunology #Tregitopes

Thiard News@F4F

@newsen.bsky.social

11 months ago

EpiVax Study Reveals Key Role of Tregitopes in Antibody Maturation for Therapeutic Applications A new study by EpiVax highlights the role of Treg epitopes in antibody maturation, offering crucial insights for therapeutic antibody development.

EpiVax Study Reveals Key Role of Tregitopes in Antibody Maturation for Therapeutic Applications #USA #Providence #EpiVax #Tregitopes #Therapeutic_Antibodies

Thiard News@F4F

@newsen.bsky.social

11 months ago

New Insights Into Antibody Maturation: The Role of Tregitopes Revealed by EpiVax Study EpiVax's latest research uncovers how Tregitopes influence antibody maturation, a discovery that could impact therapeutic antibody development.

New Insights Into Antibody Maturation: The Role of Tregitopes Revealed by EpiVax Study #USA #Providence #EpiVax #Immunology #Tregitopes

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Announces New CTO as Company Advances in Immunoinformatics Technology EpiVax, Inc. has announced Guilhem Richard as the new CTO, driving innovations and significant advancements in immunoinformatics technologies.

EpiVax Announces New CTO as Company Advances in Immunoinformatics Technology #USA #EpiVax #Guilhem_Richard #immunoinformatics #Providence,_R.I.

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Enhances Technological Leadership with Immunoinformatics Advances EpiVax proudly announces the appointment of Guilhem Richard as CTO, driving innovations in immunoinformatics technology for personalized cancer vaccines and therapeutic products.

EpiVax Enhances Technological Leadership with Immunoinformatics Advances #USA #EpiVax #Providence,_Rhode_Island #Guilhem_Richard #immunoinformatics

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Enhances Technology Leadership with the Appointment of Guilhem Richard EpiVax announces the appointment of Guilhem Richard as CTO, driving advancements in immunoinformatics and enhancing its technology leadership.

EpiVax Enhances Technology Leadership with the Appointment of Guilhem Richard #USA #Providence #EpiVax #Guilhem_Richard #immunoinformatics

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Appoints New CTO to Lead Immunoinformatics Innovations and Advancements EpiVax has appointed Guilhem Richard as its new Chief Technology Officer, enhancing its leadership in immunoinformatics and predictive tools for drug development.

EpiVax Appoints New CTO to Lead Immunoinformatics Innovations and Advancements #USA #EpiVax #Guilhem_Richard #immunoinformatics #Providence,_R.I.

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Appoints New CTO to Propel Innovations in Immunoinformatics EpiVax has announced the appointment of Guilhem Richard as Chief Technology Officer. His leadership aims to enhance immunoinformatics technologies significantly.

EpiVax Appoints New CTO to Propel Innovations in Immunoinformatics #USA #Providence #EpiVax #Guilhem_Richard #immunoinformatics

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax: Leading Innovation in Immunogenicity Risk Assessment for 2024 EpiVax showcases significant advancements in immunogenicity risk assessment for biological therapies in 2024 with innovative services and remarkable growth.

EpiVax: Leading Innovation in Immunogenicity Risk Assessment for 2024 #EpiVax #Immunogenicity #Biological_Therapies

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Celebrates Remarkable Innovations in Immunogenicity for 2024 This article reviews EpiVax's key innovations and growth in immunogenicity assessment throughout 2024, showcasing new services and significant advancements.

EpiVax Celebrates Remarkable Innovations in Immunogenicity for 2024 #USA #biotechnology #Providence #EpiVax #Immunogenicity

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax's 2024: Innovating Immunogenicity Assessment for Biologics In 2024, EpiVax, Inc. achieved remarkable advancements in immunogenicity risk assessment and opened new avenues for biologic therapeutics.

EpiVax's 2024: Innovating Immunogenicity Assessment for Biologics #USA #Providence #EpiVax #ISPRI_toolkit #PANDA_Screening

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax's Impressive Growth in Immunogenicity Services: A 2024 Review EpiVax has made significant advancements in immunogenicity risk assessment in 2024. Discover their innovative services and remarkable growth.

EpiVax's Impressive Growth in Immunogenicity Services: A 2024 Review #USA #EpiVax #ISPRI_toolkit #PANDA_Screening #Providence,_RI

Thiard News@F4F

@newsen.bsky.social

1 year ago

EpiVax Enhances Health Equity Through Key Partnerships and Groundbreaking Research EpiVax announces support for Clínica Esperanza and GAIA Vaccine Foundation, showcasing research contributions aimed at enhancing health equity for underserved communities.

EpiVax Enhances Health Equity Through Key Partnerships and Groundbreaking Research #United_States #Providence #EpiVax #GAIA_Vaccine #Clínica_Esperanza